Biotech news for Wednesday, July 1, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Unicycive Therapeutics is down ~37% in Tuesday afternoon trading after announcing it has received a Complete Response Letter from the FDA for its resubmitted NDA for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in patients with chronic kidney diseas…
HCW Biologics ( HCWB ) regained compliance with Nasdaq's minimum bid price requirement. The company will remain under a mandatory Nasdaq monitoring period through June 17, 2027. To support long-term compliance, HCW Biologics will implement a 1-for-6 reverse st…
Tashi-Delek Abivax SA ( ABVX ) shares surged Tuesday premarket after the biotech reported positive topline supplemental data from its Phase 3 ulcerative colitis maintenance program, delivering strong efficacy while easing long-term safety and cancer concerns a…
Innovent Biologics ( IVBIY ) and Eli Lilly and Company ( LLY ) Tuesday jointly announced that they have entered into a distribution and promotion agreement regarding Lilly's CDK4 & 6 inhibitor Verzenios® (abemaciclib) in mainland China . Innovent will be r…
Nuvectis Pharma ( NVCT ) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares down 19% in after-market trading. Nuvectis has also granted
Nemes Laszlo/iStock via Getty Images AbbVie ( ABBV ) said that its experimental T-cell engaging bispecific antibody Epkinly (epcoritamab) in combination with Revlimid (lenalidomide) led to better progression-free survival in large B-cell lymphoma patients who…
Tashatuvango/iStock via Getty Images The US FDA has extended the review period for Praxis Precision Medicines' ( PRAX ) application for relutrigine for SCN2A and SCN8A developmental and epileptic encephalopathies by three months to Dec. 27. The reason is that…
Thibault Renard/iStock via Getty Images Eli Lilly ( LLY ) and Regeneron Pharmaceuticals ( REGN ) are among seven drug companies selected by the US FDA to become a part of the FDA PreCheck Pilot Program, which is designed to improve US drug manufacturing capabi…
Z Squared ( ZSQR ) announced on Monday that it raised ~$15.3M via equity sales under its standby equity purchase agreement, without taking on any new debt. The company said it continues to maintain virtually no corporate debt, with the all-equity financing str…
Nuvectis Pharma ( NVCT ) announced on Monday that it has launched an underwritten public offering of its common stock. The underwriters will have a 30-day option to purchase up to an additional 15% of the shares offered by the company. The
Evommune ( EVMN ) is down ~31% in early Monday trading after reporting phase 2b data on chronic spontaneous urticaria candidate EVO756 that missed its primary goal. In the trial, patients received one of three doses or placebo. None of the active dose cohorts
Decoy Therapeutics ( DCOY ) entered into a $3.5M PIPE financing with a single healthcare-focused institutional investor. The company will use the net proceeds to advance its lead antiviral candidate into clinical trials. The PIPE is priced at $5.91/share, with…
NovaBridge Biosciences ( NBP ) appointed Srishti Gupta as CEO and a member of its board, effective July 1, succeeding Xi-Yong (Sean) Fu, who is stepping down. Fu will remain with the company in an advisory role during the leadership transition. Gupta, an